α and β subunits of inhibin/activin as sex cord-stromal differentiation markers

International Journal of Gynecological Pathology

Volumn 16, Issue 3, 1997, Pages 263-271

  Zheng, Wenxin ^b,c   Sung, C James ^a   Hanna, Iman ^a   DePetris, Giovanni ^a   Lambert Messerlian, Geralyn ^a   Steinhoff, Margaret ^a   Lauchlan, Stuart C ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c LAC USC MEDICAL CENTER   (United States)

Author keywords

Activin; Gonads; Inhibin; Markers; Ovarian neoplasms; Sex cord stromal tumors

Indexed keywords

ACTIVIN A; GONADOTROPIN; INHIBIN; MYELOPID;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; OVARY TUMOR; PRIORITY JOURNAL; SERTOLI CELL TUMOR; SEX CORD TUMOR; SOFT TISSUE SARCOMA; STROMA; THECOMA;

EID: 0030986381     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199707000-00012     Document Type: Article

References (28)

1. Vale W, Rivier C, Hsueh A, et al. Chemical and biochemical characterization of the inhibin family protein hormones. Recent Prog Horm Res 1988;44:1-34.
2. DeKrester DM, Roberson DM. The isolation and physiology of inhibin and related proteins. Biol Reprod 1989;40: 33-47.
3. Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993;48:15-23.
4. Gee DC, Russell P. The pathological assesment of ovarian neoplasms. IV: The sex cord-stromal tumors. Pathology 1981;13:235-55.
5. Coppleson M, Monaghan JM, Morrow CP, Tattersall MH. Gynecologic oncology. 2nd ed. New York: Churchill-Livingstone, 1992:961.
6. Gershenson DM. Management of early ovarian cancer: germ cell and sex cord stromal-tumors. Gynecol Oncol 1994;55 (suppl):62-72.
7. Costa MJ, DeRose PB, Roth LM, Brescia RJ, Zaloudek CJ, Cohen C. Immunohistochemical phenotype of ovarian granulosa-cell tumors. Hum Pathol 1994;25:60-6.
8. Park SH, Kim I. Histogenetic consideration of ovarian sex cord stromal tumors analyzed by expression pattern of cytokeratins, vimentin, and laminin. Correlation studies with human gonads. Pathol Res Pract 1994;190:449-56.
9. Roth LM, Liban E, Czernobilsky B. Ovarian endometrioid tumors mimicking Sertoli and Sertoli-Leydig cell tumors. Cancer 1982;50:1322-31.
10. Young RH, Prat J, Scully RE. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. A clinico-pathological analysis of 13 cases. Am J Surg Pathol 1982;6: 513-22.
11. Flemming P, Wellmann A, Maschek H, Lang H, Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. Am J Surg Pathol 1995;19:927-33.
12. Roberts VJ, Barth S, El-Roeiy A, Yen SSC. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 1993;77:1402-10.
13. Rabinovici J, Goldsmith PC, Roberts VJ, Vaughan J, Vale W, Jaffe RB. Localization and secretion of inhibin/activin subunits in the human and subhuman primate gonads. J Clin Endocrinol Metab 1991;73:1141-9.
14. Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid sub-types. Gynecol Oncol 1996;61:167-74.
15. Merchenthaler I, Culler MD, Petrusz P, Negro-Vilar A. Immunocytochemical localization of inhibin in rat and human reproductive tissues. Mol Cell Endocrinol 1987;54:239-43.
16. Meunier H, Rivier C, Evans RM, Vale W. Gonadal and extra-gonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 1988;85:247-51.
17. Lee W, Mason AJ, Schwall R, Szonyi E, Mather JP. Secretion of activin by interstitial cells in the testis. Science 1989;243:396-8.
18. Ohashi M, Hasegawa Y, Haji M, Igarashi M, Nawata H. Production of immunoreactive inhibin by a virilizing ovarian tumor (Sertoli-Leydig tumor). Clin Endocrinol (Oxf) 1990;33:613-8.
19. Yamoto M, Minami S, Nakano R, Kobayashi M. Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle. J Clin Endocrinol Metab 1992;74:989-93.
20. Vliegen MK, Schlatt S, Weinbauer GF, Bergmann M, Groome NP, Nieschlag E. Localization of inhibin/activin subunits in the testis of adult nonhuman primates and men. Cell Tissue Res 1993;273:261-8.
21. Puls LE, Hamous J, Morrow MS, Schneyer AL, MacLaughlin DT, Castravane VD. Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecol Oncol 1994;54:396-401.
22. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 1995;57: 27-32.
23. Di Simone N, Crowley WF, Wang QF, Sluss PM, Schneyer AL. Characterization of inhibin/activin subunit, follistatin, and activin type II recepors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 1996;137:486-94.
24. Schneyer AL, Hall HA, Lambert-Messerlian G, Wang QF, Sluss P, Crowley WF. Follistatin-activin complexes in human serum and follicular fluid differ immunologically and biochemically. Endocrinology 1996;137:240-7.
25. Lappohn R, Burger H, Bouma J, Bangah M, Krans M, de Bruijin H. Inhibin as a marker for granulosa cell tumors. N Engl J Med 1989;321:790-3.
26. Sluijmer AV, Heineman MJ, Evers JLH, de Jong FH. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumor. Acta Endocrinol 1993;12:311-4.
27. Seidman JD. Unclassified ovarian gonadal stromal tumors. Am J Surg Pathol 1996;20:699-706.
28. Eichhorn JH, Young RH, Clement PB. Sertoliform endometrial adenocarcinoma: a study of four cases. Int J Gynecol Pathol 1996;15:119-26.